Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cardio Diagnostics Holdings Inc. - Common stock (NQ: CDIO ) 0.4213 +0.0613 (+17.03%) Streaming Delayed Price Updated: 3:29 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cardio Diagnostics Holdings Inc. - Common stock < Previous 1 2 3 4 5 6 7 Next > CDIO Stock Earnings: Cardio Diagnostics Hldgs Misses Revenue for Q4 2023 April 04, 2024 CDIO stock results show that Cardio Diagnostics Hldgs missed on revenue for the fourth quarter of 2023. Via InvestorPlace Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre April 04, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session March 14, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire BlackRock Acquires Stake In Cardio Diagnostics February 09, 2024 --News Direct-- Via News Direct BlackRock Bolsters Wealth Management Arsenal With SpiderRock Advisors Acquisition, Expanding SMA Solutions March 08, 2024 BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strategies for U.S. wealth market. Via Benzinga Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Via Benzinga Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease March 05, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session February 16, 2024 Via Benzinga Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout February 15, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters February 15, 2024 --News Direct-- Via News Direct Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters February 14, 2024 A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. Via Benzinga BlackRock Acquires Stake In Cardio Diagnostics February 08, 2024 BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb. Via Benzinga Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters February 07, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests February 05, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests January 30, 2024 By Jeremy Golden, Benzinga Via TheNewswire.com Topics Death Exposures Death American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests January 30, 2024 --News Direct-- Via News Direct American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests January 29, 2024 Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Via Benzinga Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor January 24, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks January 09, 2024 By Jeremy Golden, Benzinga Via TheNewswire.com Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks January 09, 2024 --News Direct-- Via News Direct Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India January 08, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks January 08, 2024 An artificial intelligence-powered precision cardiovascular medicine company named Cardio Diagnostics (NASDAQ: CDIO) has launched a first-of-its-kind platform called Via Benzinga CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™ January 04, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event January 03, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session January 02, 2024 Via Benzinga Why Cardio Diagnostics Holdings Stock Is Racing Higher January 02, 2024 Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) shares are rocketing higher Tuesday after the company announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural... Via Benzinga American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code January 02, 2024 From Cardio Diagnostics Holdings, Inc. Via Business Wire Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors December 21, 2023 From Cardio Diagnostics Holdings, Inc. Via Business Wire Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association December 19, 2023 --News Direct-- Via News Direct Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association December 19, 2023 By Jeremy Golden, Benzinga Via TheNewswire.com < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
